Speaker Chi Wei Mok2019-05-29T17:20:09+08:00

Plenary & Workshop Speakers

Dr. Mok Chi Wei graduated with a Bachelor of Medicine and Bachelor of Surgery (MBBS) from University of Malaya in 2010 and subsequently joined Singhealth General Surgery Residency Programme from 2012 to 2017 for his postgraduate training. He was accredited as a specialist in General Surgery in September 2017, with the Fellowship Examinations of the Royal College of Surgeons of Edinburgh (General Surgery), before sub-specializing in breast surgery in particular breast cancer surgery.

He is currently an Associate Consultant in the Department of Surgery, Changi General Hospital, Singapore with a subspecialty interest in breast surgery. His clinical practice is mainly on breast diseases, both benign and malignant. He is currently pursuing his advanced training in oncoplastic and minimally invasive (endoscopic & robotic) breast surgery as he believes that the appearance of the breast after cancer resection is extremely important, and that every patient should have a tailored and personalized surgical solution.

Apart from his clinical commitments, he also teaches undergraduate students from the Yong Loo Lin School of Medicine, Duke-NUS Medical School and Lee Kong Chian School of medicine. In addition, Dr. Mok also serves as Core Faculty for Transitional Year Residency Programme and Clinical Faculty for General Surgery Residency Programme.

In terms of research, Dr. Mok has published extensively in breast cancer related topics and he also serves as a peer reviewer in Journal of Surgery.

• 2017: Fellow of Royal College of Surgeons of Edinburgh (FRCSEd)
• 2016: Master of Medicine (Surgery), National University of Singapore
• 2012: Member of Royal College of Surgeons of Edinburgh (MRCSEd)
• 2010: Bachelor of Medicine and Bachelor of Surgery (MBBS), University of Malaya

• Fellow, Royal College of Surgeons of Edinburgh
• Physician Faculty, Singhealth General Surgery Residency
• Core Faculty, Singhealth Postgraduate Transitional Year Residency
• Clinical Tutor, Duke-NUS Medical School
• Clinical Lecturer, Yong Loo Lin School of Medicine
• Clinical Lecturer, Lee Kong Chian School of Medicine

• 2016: Outstanding Resident Award, Singhealth RiSE Awards Ceremony
• 2015: Best Medical Poster (Second Prize), Eastern Health Alliance Annual Scientific Meeting
• 2014: Top scoring abstract (Medical Poster), 34th Congress of the European Society of Surgical Oncology (ESSO), Liverpool,UK
• 2014: Resident Educator Award, Singhealth Rise Awards Ceremony
• 2013: Outstanding Resident Award, Singhealth RiSE Awards Ceremony
• 2012: Best Oral Poster (First Prize), Eastern Health Alliance Annual Scientific Meeting


Future of E-NSM? Preliminary experience of single port 3D Endoscopic Nipple Sparing Mastectomy (E-NSM)

The preliminary experience and results of an innovative surgical technique, which incorporated a single port and 3 dimensional (3D) videoscope for E-NSM were reported. 25 patients who received 30 procedures of single port 3D E-NSM were enrolled into the current study. The mean operation time for single port 3D E-NSM and immediate prosthesis breast reconstruction (IPBR) was 181.8 ± 32.4 mins. The mean blood loss was 38.3 ± 45.3 ml (15-60). In the post-operative morbidity evaluation, one patient (6.7%) had delayed axillary wound healing, 2 (13.4%) with transient nipple ischemia but there were no cases of total nipple areolar complex necrosis and implant loss observed. In addition, there was no patient with surgical margin involvement or locoregional recurrence observed during the follow up period.

In patient-reported cosmetic outcomes, a high (93.3%) satisfaction rates were observed in terms of post-operative scar appearance, location, and length. All patients who had received 3D E-NSM and IPBR reported that they would choose the same operation again if given the chance to do so. From our preliminary experience, single port 3D E-NSM is an oncologically safe procedure with good cosmetic results, and could be a promising new technique for breast cancer patients indicated for mastectomy.